STOCKHOLM, April 27, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Radiotherapiegroep Arnhem/Deventer in the Netherlands has ordered an Elekta Unity MR-linac as well as five Versa HD™ ...
ATLANTA, Feb. 2, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that its MOSAIQ ® Oncology Information System (OIS) and Versa HD™ linear accelerator have been named "Best in KLAS" in the 2021 ...
ATLANTA and STOCKHOLM, March 1, 2013 /PRNewswire/ -- During a live global event, Elekta announced the launch of Versa HD™, an advanced linear accelerator system designed to improve patient care and ...
ATLANTA — With much pomp and circumstance, Elekta (Stockholm, Sweden) unveiled its Versa HD, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of ...
In the summer of 2014, the Macarthur Cancer Centre at Campbelltown Hospital replaced its two aging Siemens linear accelerators with Versa HD systems. The move was a huge technological leap for the ...
STOCKHOLM--(BUSINESS WIRE)--Groundbreaking linear accelerator provides single system versatility to deliver sophisticated treatments for more patients and cancer types. Elekta (STO:EKTAB) recently ...
GELSENKIRCHEN, Germany, Dec. 26, 2013 /PRNewswire/ -- On October 28, clinicians at Evangelische Kliniken Gelsenkirchen (Gelsenkirchen, Germany) launched a new era of radiation therapy speed and ...
LEEDS, UK--(BUSINESS WIRE)--Regulatory News: Leeds Cancer Centre, one of the largest providers of cancer care in the UK, will upgrade its existing treatment equipment with eight Elekta (EKTA-B.ST) ...
SPRINGFIELD - It is estimated that nearly 50 percent of cancer patients receive radiation therapy, either alone or in combination with other treatment, to kill cancerous tumors and cells and prevent ...
ATLANTA, Feb. 2, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that its MOSAIQ® Oncology Information System (OIS) and Versa HD™ linear accelerator have been named "Best in KLAS" in the 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results